• 130
  • 9
  • Favorite

Why Novavax Has Limited Downside from Here

InvestorPlace2022-02-21

Investors may almost forgive Novavax(NASDAQ:NVAX) for seeking approval for its coronavirus vaccine late. Traders are happy that NVAX stock rose alongside that of Moderna(NASDAQ:MRNA),Pfizer(NYSE:PFE),...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment9

  • Kerrisdale
    ·2022-02-22
    Also agreed vaccine markets are quite saturated, but due to high prices, many poorer countriesdo not have adequate access and supplies.. if they can't pay , then less revenues. Hope for cheaper vaccines.
    Reply
    Report
  • RO8
    ·2022-02-22
    Yes
    Reply
    Report
  • Frosty4ever
    ·2022-02-22
    Omicron sub variant is here. More transmissible and initial fear is more deadly. Large part of the world still aren't vaxx yet. 
    Reply
    Report
  • vivienne249
    ·2022-02-22
    What else is in the pipeline? Vaccine market is quite saturated 
    Reply
    Report
  • ACCY
    ·2022-02-21
    At least it is non-mRNA! That's a plus point 👍
    Reply
    Report
  • aaronh
    ·2022-02-21
    [smile] 
    Reply
    Report
  • S土豪熊貓G
    ·2022-02-21
    Long all the way! 
    Reply
    Report
  • Christoooo
    ·2022-02-21
    Ok
    Reply
    Report
  • 4XKEYQ
    ·2022-02-21
    Wow
    Reply
    Report
 
 
 
 

Most Discussed

 
 
 
 
 

7x24

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial